Cargando…
Correction: Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078274/ https://www.ncbi.nlm.nih.gov/pubmed/30082373 http://dx.doi.org/10.1136/bmjopen-2017-018794corr1 |
| _version_ | 1783345062591070208 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6078274 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60782742018-08-09 Correction: Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD) BMJ Open Correction BMJ Publishing Group 2018-08-05 /pmc/articles/PMC6078274/ /pubmed/30082373 http://dx.doi.org/10.1136/bmjopen-2017-018794corr1 Text en © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correction Correction: Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD) |
| title | Correction: Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)
|
| title_full | Correction: Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)
|
| title_fullStr | Correction: Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)
|
| title_full_unstemmed | Correction: Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)
|
| title_short | Correction: Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)
|
| title_sort | correction: randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (prevent-adpkd) |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078274/ https://www.ncbi.nlm.nih.gov/pubmed/30082373 http://dx.doi.org/10.1136/bmjopen-2017-018794corr1 |